Cites Evidence That the Company is Not Living Up to Its Potential, As Demonstrated By 26% Year-To-Date Share Price Decline, Underperformance Versus Benchmarks, Precipitous 11% Drop Post-First Quarter ...
Details How Deep Track’s Independent Nominees Will Prioritize Shareholder-Aligned Capital Allocation Decisions and Help Set Value-Maximizing Strategy in the Boardroom Visit www.RefocusDVAX.com to ...
Believes Company’s Unwillingness to Reach Mutually Acceptable Resolution – And Opposition to Giving Shareholders a Voice in the Boardroom – Underscores the Board’s Entrenchment and the Clear Need for ...
GREENWICH, Conn.--(BUSINESS WIRE)--Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders of Dynavax ...
NEW YORK(Reuters) - Life sciences investment firm Deep Track Capital is launching a board fight at Dynavax Technologies, pressing for new directors to prioritize the development of the company's ...
EMERYVILLE, Calif., Feb. 19, 2025 /PRNewswire/ — Dynavax Technologies Corporation (Nasdaq: DVAX) (“Dynavax” or the “Company”), a commercial-stage biopharmaceutical company developing and ...
What should I know about this firm? Deep Track Capital, Lp is a national financial advisory firm headquartered in Greenwich, CT. The firm has $5.1 billion under management.The firm caters to 3 clients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results